Clinical Trials Logo
  1. Home
  2. Hypersomnia
  3. NCT05183464

Analysis of New Salivary Biomarkers to Evaluate Excessive Diurnal Sleepiness in Children With Hypersomnia — BIOSOM  

Hypersomnia Clinical Trial

Official title:
Analysis of New Salivary Biomarkers to Evaluate Excessive Diurnal Sleepiness in Children With Hypersomnia

Clinical Trial Summary

Excessive diurnal sleepiness is characterized by an incapacity to stay awake, in favour of sleep occurrence. This sleepiness might be secondary to a sleep disorder; when it is not the case, it is primary hypersomnia (including narcolepsy and idiopathic hypersomnia). To date, objective measures of sleepiness can only be achieved in laboratory. Subjective techniques as scales and questionnaires are highly sensitive to inter-individual differences and cannot constitute a reliable diagnosis tool of sleepiness. Recent studies suggested that some salivary biomarkers are sensitive to sleep characteristics and thus, may allow the objective and easy evaluation of sleepiness. The objective of the study is to explore the usability of salivary biomarkers (a-amylase and oxalate) as a new non-invasive technique to evaluate sleepiness and to diagnose primary hypersomnia in children. The hypothesis of this study is that there will be a modification of salivary biomarkers concentrations with the variations of diurnal sleepiness.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05183464
Study type Observational
Source Hospices Civils de Lyon
Contact Patricia FRANCO, PU,PH
Phone 04.27.85.60.52
Email patricia.franco@chu-lyon.fr
Status Recruiting
Phase
Start date April 11, 2022
Completion date April 11, 2025
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05983731 - A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1
Completed NCT01183312 - Flumazenil for the Treatment of Primary Hypersomnia Phase 1/Phase 2
Terminated NCT03198156 - Transcranial Direct Current Stimulation Therapy for Central Hypersomnia Without Cataplexy N/A
Completed NCT03682185 - The Healthy Patterns Sleep Study Phase 3
Completed NCT00916253 - Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies N/A
Completed NCT04157244 - The Music, Sleep and Dementia Study N/A
Recruiting NCT05443373 - A Multi-Signal Based Monitoring System for CNS Hypersomnias
Completed NCT01877616 - Sleep Disorders and Their Cardiovascular Correlates in Atahualpa. N/A
Suspended NCT00427323 - Light Exposure to Treat Sleep Disruption in Older People N/A
Not yet recruiting NCT04300166 - Telemedicine and Humidification for Cpap IN Osas Key Treatment (THINK Study) N/A
Not yet recruiting NCT06404086 - RECOVER-SLEEP: Platform Protocol Phase 2
Not yet recruiting NCT06404099 - RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) Phase 2
Completed NCT01146600 - Clarithromycin for the Treatment of Hypersomnia Phase 2
Withdrawn NCT05627388 - Feasibility Study of At-Home EEG Monitoring for Hypersomnia N/A
Completed NCT01764035 - Mindfulness Therapy on Disrupted Sleep in Bipolar Disorder N/A
Completed NCT03459300 - Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)
Completed NCT00001664 - Sleep Disorders of Patients With Diseases of the Nervous System N/A
Recruiting NCT04201392 - Sleep in Psychiatric Inpatients
Suspended NCT05230394 - Patient Outcomes in Unattended and In- Lab Polysomnography N/A